In graphics: Will South Africa meet UNAIDS’s HIV targets for 2020?
Is South Africa on course to meet UNAIDS’s HIV targets set for 2020? These four graphs track our progress.
Caveat emptor: Seven things every patient should know about switching from efavirenz to dolutegravir
A new antiretroviral medicine called dolutegravir is about to be introduced in the public healthcare system. Dr Tom Boyles outlines seven things people may want to consider before switching to the new drug.
Modernising ART
Antiretroviral therapy in South Africa seems set for a revolution with a new drug combination that is highly effective and involves only one pill a day that is smaller than an aspirin. Dr Michelle Moorhouse, one of South Africa’s top HIV clinicians explains.
How HIV shaped us
HIV changed our society at a time when South Africa needed no distraction as it battled to rebuild a nation post-apartheid., write Professor Glenda Gray and Professor James A. McIntyre.
HIV and non-communicable diseases: a dangerous partnership
Over the years, HIV and the ensuing global epidemic has resulted in millions of deaths. With the advent of antiretroviral therapy, and the advocacy efforts of civil society, HIV-related mortality has significantly decreased, as has mother-to-child transmission.